menu search

Pharming group: pipeline progresses with apds phase 3 initiation

Pharming Group NV is a biotechnology firm known for its unique approach to addressing rare and genetic diseases. The company's financials show growth ...

September 9, 2023, 12:30 pm

Eledon pharmaceuticals announces first participant dosed in phase 2 bestow trial evaluating tegoprubart for the prevention of rejection in kidney transplantation

Trial to assess potential of tegoprubart-based immunosuppression to improve graft function compared to tacrolimus-based immunosuppression IRVINE, Cali...

September 5, 2023, 11:00 am

Nanostring (nstg) advances in xenotransplantation with new study

NanoString's (NSTG) nCounter Analysis System facilitates bulk tissue transcriptome profiling, revealing the intricacies of the immune response through...

August 23, 2023, 2:17 pm

Transmedics (tmdx) acquires summit aviation for organ transplant

TransMedics' (TMDX) acquisition of Summit Aviation is likely to help establish TransMedics Aviation, the first integrated national provider of air log...

August 17, 2023, 12:31 pm

2 unstoppable growth stocks you can buy with $200 right now

The modest sum of $200 is more than enough to buy shares of two exceptional growth stocks right now. TransMedics Group is singlehandedly improving an ...

August 6, 2023, 6:24 am

Why shares of transmedics group are falling friday

The company's Organ Care System is used to improve transplant outcomes for heart, liver, and lung ...

August 4, 2023, 3:17 pm

Fda rejects mesoblast's cell therapy for bone marrow transplant complications

The U.S. Food and Drug Administration had rejected Mesoblast's , cell therapy for children under 12 years of age for treating a type of complication t...

August 3, 2023, 10:01 pm

World renowned biomedical professor jonathan lakey joins cancervax board of advisors

Dr. Lakey has been recognized nationally and internationally for his groundbreaking research in cell and tissue ...

July 27, 2023, 2:01 am

Biolinerx: pdufa catalyst and pdac advancement make this worth a look

A PDUFA date of September 9, 2023 has been established for review of Motixafortide for Autologous transplant...

July 10, 2023, 7:36 pm

Allovir: 'takes one to know one'

Gilead has purchased $10.9 million in shares of Allovir, a biotech company specializing in cell therapy and organ ...

July 10, 2023, 7:13 pm

Why shares of caredx are jumping friday

CareDx specializes in diagnostic testing for transplant patients. The company's revenue declined 3% yea...

July 7, 2023, 12:26 pm

Blade air mobility: strong positioning in urban air mobility landscape

Blade is in an advantageous position being the first mover in the urban air mobility industry. The company's MediMobility division, which focuses on o...

July 4, 2023, 5:55 am

Allovir: several late-stage programs make this worth a look

Positive final results from the phase 2 study, using posoleucel for BK Virus, were presented at the American t...

July 1, 2023, 3:48 am

Bayer: phase i trial results from parkinson's cell therapy positive

Drugmaker Bayer said on Wednesday that initial testing on humans showed that its experimental stem cell therapy to treat Parkinson's disease was well-...

June 28, 2023, 2:56 am

Why shares of allovir plummeted this week

AlloVir stock fell to a 52-week low on Thursday. The company's lead therapy has begun phase 3 trials to treat kidney ...

June 23, 2023, 1:56 pm

Helocyte announces $3.22 million grant from the national cancer institute for triplex phase 2 clinical trial program

Multicenter randomized placebo-controlled trials will evaluate the ability of the cytomegalovirus (“CMV”) vaccine to enhance protective virus-spec...

June 15, 2023, 12:00 pm

Louisville family holds fundraiser for daughter’s heart transplant

Hundreds of people came out to “Joe’s Older Than Dirt” in Lyndon on Sunday to enjoy live music and drinks named in Caroline’s honor. Read Full...

June 12, 2023, 2:44 am

Successful primary engraftment of trem-cel in first five aml patients demonstrates promise of vor bio’s platform

Patients transplanted with trem-cel achieved primary neutrophil engraftment and high levels of myeloid ...

June 9, 2023, 11:30 am

Organ transplant rejection medication market to surpass usd 7.0 billion by 2031, propelled by remarkable cagr of 3.9% | transparency market research

Global organ transplant rejection medication market growth is driven by the rise in prevalence of chron...

June 7, 2023, 5:30 pm

Tscan therapeutics presents preliminary phase 1 clinical results on tsc-100 and tsc-101 at the american society of gene & cell therapy 26th annual meeting

Poster highlights Phase 1 results following treatment with TSC-100 and TSC-101 after hematopoietic cell transp...

May 17, 2023, 7:00 am


Search within

Pages Search Results: